ANX-514 News
Most Popular ANX-514 Story
Adventrx on the rise after near-death experience
The last time we checked in with Adventrx Pharmaceuticals, the San Diego-based firm was in what appeared to be its death throes. It had cut all but two of its staff, suspended its development Read more...
Latest Headlines
- January 13, 2010
- December 15, 2008
- October 20, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
